<VariationArchive VariationID="253035" VariationName="NM_003483.6(HMGA2):c.189del (p.Ala64fs)" VariationType="Deletion" Accession="VCV000253035" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2017-06-25" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="247442" VariationID="253035">
      <GeneList>
        <Gene Symbol="HMGA2" FullName="high mobility group AT-hook 2" GeneID="8091" HGNC_ID="HGNC:5009" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="65824460" stop="65966291" display_start="65824460" display_stop="65966291" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="66218239" stop="66360070" display_start="66218239" display_stop="66360070" Strand="+" />
          </Location>
          <OMIM>600698</OMIM>
          <Haploinsufficiency last_evaluated="2021-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMGA2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-09-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=HMGA2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003483.6(HMGA2):c.189del (p.Ala64fs)</Name>
      <CanonicalSPDI>NC_000012.12:65828077:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="65828078" stop="65828078" display_start="65828078" display_stop="65828078" variantLength="1" positionVCF="65828077" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="66221858" stop="66221858" display_start="66221858" display_stop="66221858" variantLength="1" positionVCF="66221857" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>A64fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.66221858del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.66221858del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.65828078del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.65828078del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016296.1" sequenceAccession="NG_016296" sequenceVersion="1" change="g.8619del">
            <Expression>NG_016296.1:g.8619del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300918.1" sequenceAccession="NM_001300918" sequenceVersion="1" change="c.189del">
            <Expression>NM_001300918.1:c.189del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287847.1" sequenceAccession="NP_001287847" sequenceVersion="1" change="p.Ala64fs">
            <Expression>NP_001287847.1:p.Ala64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001300919.1" sequenceAccession="NM_001300919" sequenceVersion="1" change="c.189del">
            <Expression>NM_001300919.1:c.189del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001287848.1" sequenceAccession="NP_001287848" sequenceVersion="1" change="p.Ala64fs">
            <Expression>NP_001287848.1:p.Ala64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330190.1" sequenceAccession="NM_001330190" sequenceVersion="1" change="c.189del">
            <Expression>NM_001330190.1:c.189del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317119.1" sequenceAccession="NP_001317119" sequenceVersion="1" change="p.Ala64fs">
            <Expression>NP_001317119.1:p.Ala64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003483.6" sequenceAccession="NM_003483" sequenceVersion="6" change="c.189del" MANESelect="true">
            <Expression>NM_003483.6:c.189del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003474.1" sequenceAccession="NP_003474" sequenceVersion="1" change="p.Ala64fs">
            <Expression>NP_003474.1:p.Ala64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003484.1" sequenceAccession="NM_003484" sequenceVersion="1" change="c.189del">
            <Expression>NM_003484.1:c.189del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003475.1" sequenceAccession="NP_003475" sequenceVersion="1" change="p.Ala64fs">
            <Expression>NP_003475.1:p.Ala64fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645369522" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="600698.0003" DB="OMIM" />
        <XRef Type="rs" ID="1114167320" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003483.6(HMGA2):c.189del (p.Ala64fs) AND Silver-Russell syndrome 1" Accession="RCV000491565" Version="2">
        <ClassifiedConditionList TraitSetID="6394">
          <ClassifiedCondition DB="MedGen" ID="C5393125">Silver-Russell syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003483.6(HMGA2):c.189del (p.Ala64fs) AND Silver-Russell syndrome 5" Accession="RCV001174519" Version="3">
        <ClassifiedConditionList TraitSetID="53795">
          <ClassifiedCondition DB="MedGen" ID="C5394456">Silver-Russell syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-02-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-13" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-06-25" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28796236</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="53795" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53373" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Silver-Russell syndrome 5</ElementValue>
                <XRef ID="MONDO:0020795" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SRS5</ElementValue>
                <XRef Type="MIM" ID="618908" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference ≥1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.</Attribute>
                <XRef ID="NBK1324" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18465" />
                <XRef ID="18465" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301499</ID>
                <ID Source="BookShelf">NBK1324</ID>
              </Citation>
              <XRef ID="C5394456" DB="MedGen" />
              <XRef ID="MONDO:0020795" DB="MONDO" />
              <XRef Type="MIM" ID="618908" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6394" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15879" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Silver-Russell syndrome 1</ElementValue>
                <XRef ID="MONDO:0020796" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRS</ElementValue>
                <XRef ID="GTR000327158" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RSS</ElementValue>
                <XRef Type="MIM" ID="180860" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SRS1</ElementValue>
                <XRef Type="MIM" ID="180860" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4870" />
                <XRef ID="4870" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Silver-Russell Syndrome (SRS) is typically characterized by asymmetric gestational growth restriction resulting in affected individuals being born small for gestational age, with relative macrocephaly at birth (head circumference ≥1.5 SD above birth weight and/or length), prominent forehead usually with frontal bossing, and frequently body asymmetry. This is followed by postnatal growth failure, and in some cases progressive limb length discrepancy and feeding difficulties. Additional clinical features include triangular facies, fifth-finger clinodactyly, and micrognathia with narrow chin. Except for the limb length asymmetry, the growth failure is proportionate and head growth normal. The average adult height in untreated individuals is ~3.1±1.4 SD below the mean. The Netchine-Harbison Clinical Scoring System (NH-CSS) is a sensitive diagnostic scoring system. Clinical diagnosis can be established in an individual who meets at least four of the NH-CSS clinical criteria – prominent forehead/frontal bossing and relative macrocephaly at birth plus two additional findings – and in whom other disorders have been ruled out.</Attribute>
                <XRef ID="NBK1324" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301499</ID>
                <ID Source="BookShelf">NBK1324</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061987</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="813" DB="Orphanet" />
              <XRef ID="C5393125" DB="MedGen" />
              <XRef ID="MONDO:0020796" DB="MONDO" />
              <XRef Type="MIM" ID="180860" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="576348" SubmissionDate="2016-08-17" DateLastUpdated="2017-06-25" DateCreated="2017-06-25">
        <ClinVarSubmissionID localKey="SUB1777339" submittedAssembly="hg19" title="SUB1777339" />
        <ClinVarAccession Accession="SCV000297815" DateUpdated="2017-06-25" DateCreated="2017-06-25" Type="SCV" Version="1" SubmitterName="Centre de Recherche Saint Antoine,  Université Pierre et Marie Curie" OrgID="504835" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMGA2">
              <Name>high mobility group AT-hook 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003483.4:c.189del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="180860" />
          </Trait>
        </TraitSet>
        <StudyName>Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes Silver-Russell Syndrome</StudyName>
        <StudyDescription>Indentification of new genes implicated in human growth physiology</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>SUB1777339</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2644827" SubmissionDate="2020-06-12" DateLastUpdated="2024-03-10" DateCreated="2020-06-15">
        <ClinVarSubmissionID localKey="600698.0003_SILVER-RUSSELL SYNDROME 5" title="HMGA2, 1-BP DEL, NT189_SILVER-RUSSELL SYNDROME 5" />
        <ClinVarAccession Accession="SCV001337659" DateUpdated="2024-03-10" DateCreated="2020-06-15" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male patient with Silver-Russell syndrome (SRS5; 618908), Abi Habib et al. (2018) identified heterozygosity for a 1-bp deletion (c.189del, NM_003483.4) in the HMGA2 gene, causing a frameshift predicted to result in elongation of the protein (Ala64LeufsExt102). Parental DNA was unavailable for study, but the father's short stature suggested that the deletion was paternally inherited.</Attribute>
              <Citation>
                <ID Source="PubMed">28796236</ID>
              </Citation>
              <XRef DB="OMIM" ID="618908" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HMGA2" />
          </GeneList>
          <Name>HMGA2, 1-BP DEL, NT189</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, NT189</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600698.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SILVER-RUSSELL SYNDROME 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2644827" TraitType="Disease" MappingType="Name" MappingValue="SILVER-RUSSELL SYNDROME 5" MappingRef="Preferred">
        <MedGen CUI="C5394456" Name="Silver-Russell syndrome 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="576348" TraitType="Disease" MappingType="XRef" MappingValue="180860" MappingRef="OMIM">
        <MedGen CUI="C5393125" Name="Silver-Russell syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

